Alan R Tall Selected Research

Tangier Disease

1/2018	Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
11/2003	Retinoic acid receptor-mediated induction of ABCA1 in macrophages.
10/2003	ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux.
9/2003	Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I.
1/2003	A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan R Tall Research Topics

Disease

68	Atherosclerosis 01/2022 - 06/2002
20	Atherosclerotic Plaque (Atheroma) 01/2022 - 06/2005
18	Inflammation (Inflammations) 01/2022 - 06/2005
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2004
8	Thrombosis (Thrombus) 12/2021 - 11/2007
8	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 03/2007
8	Type 2 Diabetes Mellitus (MODY) 01/2019 - 11/2008
8	Coronary Disease (Coronary Heart Disease) 01/2019 - 02/2003
7	Obesity 01/2020 - 03/2004
7	Insulin Resistance 05/2014 - 04/2009
6	Neoplasms (Cancer) 01/2022 - 08/2012
5	Tangier Disease 01/2018 - 01/2003
5	Myocardial Infarction 01/2018 - 08/2012
5	Hypercholesterolemia 09/2016 - 11/2007
4	Cholesteryl Ester Transfer Protein Deficiency 01/2018 - 02/2003
4	Leukocytosis (Pleocytosis) 07/2013 - 06/2010
3	Dyslipidemias (Dyslipidemia) 01/2022 - 04/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 03/2004
3	Vascular Diseases (Vascular Disease) 01/2017 - 05/2008
3	Necrosis 04/2016 - 06/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2005
2	Fatty Liver 01/2022 - 01/2016
2	Infections 12/2021 - 02/2015
2	Weight Loss (Weight Reduction) 01/2020 - 05/2014
2	Diabetes Mellitus 01/2019 - 01/2018
2	Leukemia 09/2016 - 02/2013
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 02/2013 - 06/2010
2	Body Weight (Weight, Body) 09/2011 - 01/2005
1	Peritonitis 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Polycythemia (Erythrocytosis) 01/2022
1	Cytokine Release Syndrome 12/2021
1	COVID-19 12/2021
1	Pneumonia (Pneumonitis) 12/2021
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 10/2020
1	Weight Gain 01/2020
1	Peripheral Arterial Disease 01/2020

Drug/Important Bio-Agent (IBA)

56	CholesterolIBA 01/2022 - 06/2002
24	HDL LipoproteinsIBA 01/2021 - 06/2004
16	LipidsIBA 01/2021 - 06/2002
15	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2018 - 09/2003
11	oxidized low density lipoproteinIBA 01/2022 - 06/2002
11	HDL CholesterolIBA 01/2019 - 02/2003
11	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2017 - 01/2003
10	Apolipoproteins E (ApoE)IBA 01/2020 - 10/2006
9	Insulin (Novolin)FDA Link 12/2016 - 03/2004
8	Lipoproteins (Lipoprotein)IBA 01/2022 - 06/2002
8	Liver X ReceptorsIBA 01/2022 - 11/2003
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2007
8	Cholesterol Ester Transfer ProteinsIBA 01/2017 - 06/2002
7	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2002
6	InflammasomesIBA 12/2021 - 01/2018
6	Adenosine Triphosphate (ATP)IBA 01/2021 - 02/2006
6	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018 - 01/2005
6	LDL CholesterolIBA 09/2017 - 08/2010
6	LDL Receptors (LDL Receptor)IBA 01/2016 - 01/2005
5	Transcription Factors (Transcription Factor)IBA 01/2016 - 11/2003
4	Phospholipids (Phosphatides)FDA LinkGeneric 12/2021 - 01/2003
4	ApolipoproteinsIBA 01/2016 - 06/2002
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 07/2015
3	anacetrapibIBA 01/2018 - 07/2010
3	Apolipoproteins B (ApoB)IBA 05/2012 - 06/2002
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	Antisense OligonucleotidesIBA 01/2022 - 01/2020
2	CME-Carbodiimide (CMEC)IBA 01/2020 - 01/2019
2	Interleukin-18 (Interleukin 18)IBA 01/2019 - 01/2018
2	InterleukinsIBA 01/2019 - 01/2018
2	SterolsIBA 09/2017 - 09/2007
2	Scavenger Receptors (Scavenger Receptor)IBA 09/2017 - 08/2007
2	evacetrapibIBA 01/2017 - 12/2015
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2007
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2016 - 05/2014
2	Interleukin-3 (Interleukin 3)IBA 09/2016 - 05/2014
2	OxysterolsIBA 04/2016 - 02/2010
2	EnzymesIBA 01/2016 - 09/2005
2	Sirolimus (Rapamycin)FDA Link 05/2014 - 05/2012
2	TOR Serine-Threonine KinasesIBA 05/2014 - 05/2012
2	Insulin ReceptorIBA 03/2013 - 04/2006
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 03/2013 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 09/2005
2	torcetrapibIBA 11/2009 - 11/2007
2	Streptozocin (Streptozotocin)FDA Link 09/2005 - 06/2002
1	liproxstatin-1IBA 01/2022
1	Dinoprostone (PGE2)FDA Link 01/2022
1	Erythropoietin FDA Link 01/2022
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2022
1	VaccinesIBA 12/2021
1	Poly I-CIBA 12/2021
1	Viral RNAIBA 12/2021
1	Staphylococcal Protein A (Protein A)IBA 12/2021
1	Virulence Factors (Pathogenicity Factors)IBA 12/2021
1	1-penicillamyl-Leu(2)- oxytocinIBA 12/2021
1	Janus Kinase 2IBA 01/2020
1	Interferon Type IIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	fedratinibIBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2019

Therapy/Procedure

9	Therapeutics 12/2021 - 02/2013
4	Transplantation 05/2014 - 06/2010
1	Glycemic Control 01/2020